/ /

  • linkedin
  • Increase Font
  • Sharebar

    AACE/ACE Lipid Guidelines Define Extreme CVD Risk

    The lipid management guidelines issued by the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) in April 2017 take a step back in time and re-affirm the use of LDL-C targets to help minimize cardiovascular risk in all patients, and especially those with T2DM. The shift away from the 2013 recommendations by cardiology societies, which focus on primary and secondary treatment categories and medications, includes a first-ever "extreme risk" patient category for whom an LDL-C level of < 55 mg/dL is advised. More discussion around targets vs no targets is ensured.

    In this short slide show, we summarize the "extreme risk" category and treatment targets as well as other updates to the 2017 AACE/ACE statement.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available